AstraZeneca to invest £11bn in China after rowing back on UK expansion
Keir Starmer says the move, announced during his trip to Beijing, will help support thousands of British jobsBritain’s biggest drugmaker AstraZeneca is to invest $15bn (£11bn) in China, it announced during Keir Starmer’s visit to the country, just months after cooling on plans for expansion in the UK.The Cambridge-based company said it would spend the money by 2030 to expand medicines manufacturing and research and development in China, where it already has a big presence. It includes the construction of a $2.5bn research hub in Beijing, which was announced last March. Continue reading...
Keir Starmer says the move, announced during his trip to Beijing, will help support thousands of British jobs
Britain’s biggest drugmaker AstraZeneca is to invest $15bn (£11bn) in China, it announced during Keir Starmer’s visit to the country, just months after cooling on plans for expansion in the UK.
The Cambridge-based company said it would spend the money by 2030 to expand medicines manufacturing and research and development in China, where it already has a big presence. It includes the construction of a $2.5bn research hub in Beijing, which was announced last March. Continue reading...
What's Your Reaction?
